Home/Filings/4/0001209191-10-048882
4//SEC Filing

Bianchi Annette 4

Accession 0001209191-10-048882

CIK 0001316175other

Filed

Oct 3, 8:00 PM ET

Accepted

Oct 4, 8:15 PM ET

Size

6.1 KB

Accession

0001209191-10-048882

Insider Transaction Report

Form 4
Period: 2010-09-30
Transactions
  • Award

    Stock Option (right to buy)

    2010-09-30+12,00012,000 total
    Exercise: $4.19Exp: 2020-09-30Common Stock (12,000 underlying)
Footnotes (2)
  • [F1]The option vests and becomes exercisable in equal monthly installments over a one-year period from July 9, 2010.
  • [F2]VantagePoint Venture Associates IV, LLC has the sole power to exercise the option, and sole voting and investment power with respect to the shares underlying the option. Ms. Bianchi disclams beneficial ownership thereof except to the extent of her pecuniary interest therein.

Issuer

Anthera Pharmaceuticals Inc

CIK 0001316175

Entity typeother

Related Parties

1
  • filerCIK 0001336036

Filing Metadata

Form type
4
Filed
Oct 3, 8:00 PM ET
Accepted
Oct 4, 8:15 PM ET
Size
6.1 KB